▶
Scaling Imbalanced ML from Financial Fraud to Clinical Risk
Financial fraud detection and healthcare AI share the same core challenge: rare events in noisy, multimodal data where missing a positive case is costly.
Timestamps:
00:00 The “accuracy illusion” in imbalanced ML
03:19 Rethinking objectives beyond accuracy
05:00 Fraud detection as a blueprint for healthcare AI
06:10 Clinical risk, sepsis, and alert fatigue
07:18 Modeling, threshold tuning, and deployment trade-offs
Maral Karbaschi (Researcher & Academic Advisor, Alzahra University / AbroadIn) presents Scaling Imbalanced ML from Financial Fraud to Clinical Risk: A Practical Deployment Framework — a production-oriented approach built on fraud detection systems where class weighting, ensemble methods, threshold tuning, and monitoring pipelines are already proven at scale.
The key idea is transfer, not reinvention. Techniques used to detect rare financial events can be adapted to clinical risk prediction, including patient phenotyping, rare disease identification, and adverse event detection.
What changes is not the data structure, but the cost of failure. In healthcare, the same imbalance exists, but the tolerance for missed events is significantly lower.
The framework extends beyond modelling into deployment: decision thresholds, system-level trade-offs, and operational constraints that determine whether a model works in practice or fails despite strong metrics.
📌 Applied Healthcare AI Summit 2026 — what actually works in real-world healthcare AI, from pilots to production systems.
#ClinicalAI #MachineLearning #FraudDetection #MLOps
